EMERGO THERAPEUTICS

emergo-therapeutics-logo

Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses. It is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Emergoโ€™s therapeutic interventions are focused on reducing the production of inflammatory cytokines from mast cells. Emergo is headquartered in Durham, North Carolina.

#SimilarOrganizations #People #Financial #Website #More

EMERGO THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Clinical Trials Pharmaceutical

Founded:
2017-01-01

Address:
Durham, North Carolina, United States

Country:
United States

Website Url:
http://www.emergotherapeutics.com

Total Employee:
11+

Status:
Active

Total Funding:
16.02 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics


Similar Organizations

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.


Current Advisors List

jack-bailey_image

Jack Bailey Board Member @ Emergo Therapeutics
Board_member
2019-05-01

Current Employees Featured

karen-adams_image

Karen Adams
Karen Adams CFO @ Emergo Therapeutics
CFO
2017-06-01

not_available_image

Robin Hyde-DeRuyscher
Robin Hyde-DeRuyscher Founder & CSO @ Emergo Therapeutics
Founder & CSO

moise-khayrallah_image

Moise Khayrallah
Moise Khayrallah CEO @ Emergo Therapeutics
CEO
2017-04-01

Founder


not_available_image

Robin Hyde-DeRuyscher

Investors List

north-carolina-biotechnology-center_image

North Carolina Biotechnology Center

North Carolina Biotechnology Center investment in Debt Financing - Emergo Therapeutics

venture-capital-multiplier-fund_image

Venture Capital Multiplier Fund

Venture Capital Multiplier Fund investment in Series A - Emergo Therapeutics

wolfpack-investor-network_image

Wolfpack Investor Network

Wolfpack Investor Network investment in Series A - Emergo Therapeutics

carolina-angel-network_image

Carolina Angel Network

Carolina Angel Network investment in Series A - Emergo Therapeutics

rex-health-ventures_image

Rex Health Ventures

Rex Health Ventures investment in Series A - Emergo Therapeutics

south-carolina-angel-network_image

VentureSouth

VentureSouth investment in Series A - Emergo Therapeutics

Official Site Inspections

http://www.emergotherapeutics.com

  • Host name: 108.82.187.35.bc.googleusercontent.com
  • IP address: 35.187.82.108
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Emergo Therapeutics"

About Emergo - Emergo Therapeutics

Emergo Therapeutics is focused on developing drugs to modulate inflammatory responses. Emergo believes that inflammation is responsible for some of the most damaging symptoms โ€ฆSee details»

The Emergo Team - Emergo Therapeutics

After Novalon was acquired by Karo Bio AB (Sweden), he stayed on and managed internal drug discovery efforts and external collaborations. Robin moved to Affinergy in 2003, focusing on โ€ฆSee details»

Emergo Therapeutics - LinkedIn

Emergo Therapeutics Pharmaceutical Manufacturing Durham, North Carolina 292 followers Bringing the Immune Response Back into BalanceSee details»

Emergo Therapeutics - Crunchbase Company Profile

Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses. It is focused on developing drugs to modulate โ€ฆSee details»

Emergo Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Emergo Therapeutics, Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»

Emergo Therapeutics - Overview, News & Similar companies

View Emergo Therapeutics (www.emergotherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Emergo Therapeutics Company Profile | Management and

6208 Fayetteville Rd Ste 104, Durham, North Carolina, 27713, United StatesSee details»

Emergo Therapeutics Inc. | North Carolina Biotech Center

Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, โ€ฆSee details»

Emergo Therapeutics, Inc.:Company Profile & Technical Research ...

Emergo Therapeutics, Inc. is a company that provides Allergy drugs, Immune system, Clinical trial and more. Emergo Therapeutics, Inc. is headquartered in United States North Carolina.See details»

Emergo Therapeutics - Craft

Emergo Therapeutics has 5 employees at their 1 location and $12 m in total funding,. See insights on Emergo Therapeutics including office locations, competitors, revenue, financials, โ€ฆSee details»

Our Board of Directors - Emergo Therapeutics

Bobby Helmedag, MBA. Managing Director, Rex Health Ventures. Bobby oversees the day-to-day operations of the fund. Bobby serves as the Rex Health Ventures Board representative for โ€ฆSee details»

Emergo Therapeutics - VentureRadar

Emergo Therapeutics VentureRadar profile. Find out more about Emergo Therapeutics, healthcare.See details»

Emergo Therapeutics - 2025 Company Profile - Tracxn

Mar 8, 2025 Emergo Therapeutics - Developer of treatment for the treatment of inflammatory diseases. Raised a total funding of $16M over 3 rounds from 5 investors. Founded by Robin โ€ฆSee details»

Emergo Therapeutics (Biotechnology - United States)

Description. Emergo Therapeutics specializes in balancing immune responses to improve health outcomes. Operating within the biotechnology and life sciences sectors, the company is โ€ฆSee details»

Emergo Therapeutics - PitchBook

Emergo Therapeutics General Information Description. Developer of therapeutic drugs designed to improve immune system function in various indications. The company's drugs target the โ€ฆSee details»

Emergo Therapeutics - Contacts, Employees, Board Members

Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses.See details»

Emergo Therapeutics - Phone, Email, Employees, CEO, VP, 2024

Emergo Therapeutics (https://www.emergotherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Our Current Drug Pipeline - Emergo Therapeutics

Emergo is at the forefront of developing pioneering treatments for indications that currently lack effective treatments.See details»

New study results reinforce Tagrisso as the backbone therapy for โ€ฆ

Mar 25, 2025 New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZenecaโ€™s Tagrisso (osimertinib), as โ€ฆSee details»

Emergo Raises $12 Million in Series A Round

Emergo Therapeutics Raises $12 Million in Venture Funding, Led by REX Health Ventures. RALEIGH, N.C. โ€“ May 23, 2018 โ€“ Emergo Therapeutics has raised $12 million in a Series A โ€ฆSee details»

linkstock.net © 2022. All rights reserved